Our research is focused on contributing to improving the lives of people who suffer from malaria.

We do this through the discovery and pre-clinical investigation of new drug leads for malaria prevention and treatment and the identification of novel drug targets.

We are also investigating the mode of action of a clinically used malaria drug called proguanil, which has been used for decades for malaria prevention and treatment as part of a drug combination. We found that proguanil has a novel activity that occurs via a unique slow action mechanism. This finding may have implications for how proguanil is used clinically. We are currently investigating this novel mode of action.